Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2200566238;66239;66240 chr2:178582443;178582442;178582441chr2:179447170;179447169;179447168
N2AB2036461315;61316;61317 chr2:178582443;178582442;178582441chr2:179447170;179447169;179447168
N2A1943758534;58535;58536 chr2:178582443;178582442;178582441chr2:179447170;179447169;179447168
N2B1294039043;39044;39045 chr2:178582443;178582442;178582441chr2:179447170;179447169;179447168
Novex-11306539418;39419;39420 chr2:178582443;178582442;178582441chr2:179447170;179447169;179447168
Novex-21313239619;39620;39621 chr2:178582443;178582442;178582441chr2:179447170;179447169;179447168
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Q
  • RefSeq wild type transcript codon: CAA
  • RefSeq wild type template codon: GTT
  • Domain: Fn3-47
  • Domain position: 50
  • Structural Position: 67
  • Q(SASA): 0.6698
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Q/H rs747951231 -0.405 0.954 N 0.493 0.263 0.232513804876 gnomAD-2.1.1 4.44E-05 None None None None N None 0 0 None 0 0 None 3.26883E-04 None 0 8.92E-06 0
Q/H rs747951231 -0.405 0.954 N 0.493 0.263 0.232513804876 gnomAD-4.0.0 3.21742E-05 None None None None N None 0 0 None 0 0 None 0 0 3.59899E-06 4.98736E-04 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Q/A 0.327 likely_benign 0.3183 benign -0.366 Destabilizing 0.209 N 0.399 neutral None None None None N
Q/C 0.8554 likely_pathogenic 0.8629 pathogenic 0.149 Stabilizing 0.991 D 0.469 neutral None None None None N
Q/D 0.9072 likely_pathogenic 0.9223 pathogenic -0.089 Destabilizing 0.561 D 0.37 neutral None None None None N
Q/E 0.2028 likely_benign 0.2227 benign -0.097 Destabilizing 0.285 N 0.403 neutral N 0.436686924 None None N
Q/F 0.926 likely_pathogenic 0.922 pathogenic -0.443 Destabilizing 0.818 D 0.501 neutral None None None None N
Q/G 0.7011 likely_pathogenic 0.6863 pathogenic -0.596 Destabilizing 0.561 D 0.481 neutral None None None None N
Q/H 0.6788 likely_pathogenic 0.68 pathogenic -0.512 Destabilizing 0.954 D 0.493 neutral N 0.51622793 None None N
Q/I 0.5022 ambiguous 0.4959 ambiguous 0.162 Stabilizing 0.39 N 0.495 neutral None None None None N
Q/K 0.2045 likely_benign 0.2538 benign -0.027 Destabilizing 0.166 N 0.413 neutral N 0.415277076 None None N
Q/L 0.2514 likely_benign 0.2264 benign 0.162 Stabilizing None N 0.276 neutral N 0.42709158 None None N
Q/M 0.4373 ambiguous 0.4079 ambiguous 0.529 Stabilizing 0.818 D 0.481 neutral None None None None N
Q/N 0.6683 likely_pathogenic 0.6773 pathogenic -0.417 Destabilizing 0.561 D 0.357 neutral None None None None N
Q/P 0.3133 likely_benign 0.2781 benign 0.015 Stabilizing 0.662 D 0.528 neutral N 0.450005725 None None N
Q/R 0.2418 likely_benign 0.2878 benign 0.13 Stabilizing 0.003 N 0.187 neutral N 0.453891392 None None N
Q/S 0.5333 ambiguous 0.5001 ambiguous -0.436 Destabilizing 0.209 N 0.402 neutral None None None None N
Q/T 0.3661 ambiguous 0.3583 ambiguous -0.276 Destabilizing 0.002 N 0.248 neutral None None None None N
Q/V 0.2934 likely_benign 0.2912 benign 0.015 Stabilizing 0.209 N 0.446 neutral None None None None N
Q/W 0.93 likely_pathogenic 0.9367 pathogenic -0.36 Destabilizing 0.991 D 0.481 neutral None None None None N
Q/Y 0.8905 likely_pathogenic 0.8882 pathogenic -0.131 Destabilizing 0.965 D 0.529 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.